Flc Capital Advisors Merck & Co., Inc. Transaction History

Flc Capital Advisors

$431 Million
Q4 2024

A detailed history of Flc Capital Advisors transactions in Merck & Co., Inc. stock. As of the latest transaction made, Flc Capital Advisors holds 79,026 shares of MRK stock, worth $7.61 Million. This represents 1.82% of its overall portfolio holdings.

Number of Shares

79,026

Previous 81,505 3.04%

Holding current value

$7.61 Million

Previous $9.26 Million 15.06%

% of portfolio

1.82%

Previous 2.15%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 16, 2025	SELL	$96.31 - $114.76 $238,752 - $284,490	-2,479 Reduced 3.04%	79,026 $7.86 Million
Q3 2024 Oct 16, 2024	SELL	$111.15 - $128.97 $332,338 - $385,620	-2,990 Reduced 3.54%	81,505 $9.26 Million
Q2 2024 Jul 15, 2024	SELL	$123.8 - $132.96 $13,370 - $14,359	-108 Reduced 0.13%	84,495 $10.5 Million
Q1 2024 May 03, 2024	SELL	$113.24 - $131.95 $109,616 - $127,727	-968 Reduced 1.13%	84,603 $11.2 Million
Q4 2023 Jan 18, 2024	BUY	$100.18 - $109.02 $270,185 - $294,026	2,697 Added 3.25%	85,571 $9.33 Million
Q3 2023 Jan 18, 2024	SELL	$102.95 - $114.33 $49,724 - $55,221	-483 Reduced 0.58%	82,874 $8.53 Million
Q1 2023 Apr 26, 2023	SELL	$102.94 - $114.86 $20,588 - $22,972	-200 Reduced 0.24%	83,357 $8.87 Million
Q4 2022 Jan 27, 2023	SELL	$87.44 - $112.11 $7,782 - $9,977	-89 Reduced 0.11%	83,557 $9.27 Million
Q3 2022 Oct 14, 2022	SELL	$84.53 - $94.96 $45,815 - $51,468	-542 Reduced 0.64%	83,646 $7.2 Million
Q2 2022 Jul 27, 2022	SELL	$83.49 - $94.64 $87,747 - $99,466	-1,051 Reduced 1.23%	84,188 $7.68 Million
Q1 2022 Apr 25, 2022	BUY	$73.51 - $82.4 $748,993 - $839,573	10,189 Added 13.58%	85,239 $6.99 Million
Q4 2021 Jan 26, 2022	BUY	$72.28 - $90.54 $106,757 - $133,727	1,477 Added 2.01%	75,050 $5.75 Million
Q3 2021 Oct 13, 2021	BUY	$71.68 - $78.83 $146,227 - $160,813	2,040 Added 2.85%	73,573 $5.53 Million
Q2 2021 Aug 12, 2021	BUY	$70.31 - $77.77 $82,614 - $91,379	1,175 Added 1.67%	71,533 $5.56 Million
Q1 2021 Apr 23, 2021	BUY	$68.86 - $81.11 $310,627 - $365,887	4,511 Added 6.85%	70,358 $5.42 Million
Q4 2020 Feb 10, 2021	BUY	$71.77 - $79.65 $239,065 - $265,314	3,331 Added 5.33%	65,847 $5.39 Million
Q3 2020 Oct 23, 2020	BUY	$73.18 - $82.95 $142,115 - $161,088	1,942 Added 3.21%	62,516 $4.89 Million
Q2 2020 Jul 10, 2020	BUY	$70.42 - $80.13 $227,597 - $258,980	3,232 Added 5.64%	60,574 $4.82 Million
Q1 2020 Apr 09, 2020	BUY	$63.36 - $87.82 $263,514 - $365,243	4,159 Added 7.82%	57,342 $4.41 Million
Q4 2019 Jan 13, 2020	SELL	$77.58 - $87.54 $71,761 - $80,974	-925 Reduced 1.71%	53,183 $4.84 Million
Q3 2019 Oct 29, 2019	SELL	$76.08 - $82.93 $91,296 - $99,516	-1,200 Reduced 2.17%	54,108 $4.56 Million
Q2 2019 Aug 05, 2019	SELL	$69.84 - $81.59 $13,269 - $15,502	-190 Reduced 0.34%	55,308 $4.65 Million
Q1 2019 May 13, 2019	BUY	$69.58 - $79.36 $153,910 - $175,544	2,212 Added 4.15%	55,498 $4.62 Million
Q4 2018 Feb 11, 2019	BUY	$65.24 - $75.71 $3.48 Million - $4.03 Million	53,286 New	53,286 $4.07 Million

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $244B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Flc Capital Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Flc Capital Advisors with notifications on news.

Account

Flc Capital Advisors Merck & Co., Inc. Transaction History